elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57012617-1A696E9C-DDE4-457A-BFBF-B61EEA5467FC
Q57012617-1A696E9C-DDE4-457A-BFBF-B61EEA5467FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57012617-1A696E9C-DDE4-457A-BFBF-B61EEA5467FC
On the origins of drug polypharmacology
P2860
Q57012617-1A696E9C-DDE4-457A-BFBF-B61EEA5467FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57012617-1A696E9C-DDE4-457A-BFBF-B61EEA5467FC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b8f284c54268a177625c6ee1cfdfee7d510b45c5
P2860
Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.